

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.52391373 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.28491057 |
| 3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.21434902 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.17208234 |
| 5 | vocalization behavior (GO:0071625) | 5.15789666 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.12330244 |
| 7 | synaptic vesicle maturation (GO:0016188) | 5.10897274 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.06577723 |
| 9 | glutamate secretion (GO:0014047) | 4.94448145 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.89506770 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 4.86275248 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.73980544 |
| 13 | protein localization to synapse (GO:0035418) | 4.70303710 |
| 14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.53324353 |
| 15 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.48984443 |
| 16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.32811076 |
| 17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.30196981 |
| 18 | exploration behavior (GO:0035640) | 4.29938229 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.25539749 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.24752454 |
| 21 | neuronal action potential propagation (GO:0019227) | 4.23458796 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.03755210 |
| 23 | layer formation in cerebral cortex (GO:0021819) | 4.03677585 |
| 24 | regulation of synapse structural plasticity (GO:0051823) | 3.99955316 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.93696609 |
| 26 | nucleobase catabolic process (GO:0046113) | 3.93049465 |
| 27 | glutamate receptor signaling pathway (GO:0007215) | 3.90781414 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 3.82961271 |
| 29 | neuron recognition (GO:0008038) | 3.81899908 |
| 30 | proline transport (GO:0015824) | 3.80839641 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 3.79389393 |
| 32 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.72350590 |
| 33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.71202324 |
| 34 | dendritic spine morphogenesis (GO:0060997) | 3.69208960 |
| 35 | activation of protein kinase A activity (GO:0034199) | 3.66182368 |
| 36 | postsynaptic membrane organization (GO:0001941) | 3.61854710 |
| 37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.58524953 |
| 38 | gamma-aminobutyric acid transport (GO:0015812) | 3.51154119 |
| 39 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.47430431 |
| 40 | positive regulation of membrane potential (GO:0045838) | 3.47368911 |
| 41 | axonal fasciculation (GO:0007413) | 3.45697473 |
| 42 | presynaptic membrane assembly (GO:0097105) | 3.43884600 |
| 43 | regulation of postsynaptic membrane potential (GO:0060078) | 3.43663596 |
| 44 | long-term memory (GO:0007616) | 3.42914765 |
| 45 | neurotransmitter transport (GO:0006836) | 3.39415695 |
| 46 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.37024623 |
| 47 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.35810846 |
| 48 | positive regulation of synapse maturation (GO:0090129) | 3.35371197 |
| 49 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.32421817 |
| 50 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.31669908 |
| 51 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.30526461 |
| 52 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.25777368 |
| 53 | regulation of synaptic plasticity (GO:0048167) | 3.25130824 |
| 54 | cellular potassium ion homeostasis (GO:0030007) | 3.22645082 |
| 55 | synaptic vesicle endocytosis (GO:0048488) | 3.20063500 |
| 56 | regulation of neurotransmitter levels (GO:0001505) | 3.19291597 |
| 57 | regulation of neurotransmitter secretion (GO:0046928) | 3.18764754 |
| 58 | regulation of vesicle fusion (GO:0031338) | 3.18311265 |
| 59 | detection of calcium ion (GO:0005513) | 3.18285757 |
| 60 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.18194457 |
| 61 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.16729843 |
| 62 | long-term synaptic potentiation (GO:0060291) | 3.16700795 |
| 63 | transmission of nerve impulse (GO:0019226) | 3.15655292 |
| 64 | presynaptic membrane organization (GO:0097090) | 3.13872444 |
| 65 | dendrite morphogenesis (GO:0048813) | 3.12856688 |
| 66 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.12233372 |
| 67 | cell communication by electrical coupling (GO:0010644) | 3.09601887 |
| 68 | vesicle transport along microtubule (GO:0047496) | 3.07226864 |
| 69 | membrane depolarization during action potential (GO:0086010) | 3.06511921 |
| 70 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.05991100 |
| 71 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.04031372 |
| 72 | membrane depolarization (GO:0051899) | 3.02388683 |
| 73 | establishment of mitochondrion localization (GO:0051654) | 3.00452486 |
| 74 | neuromuscular process controlling balance (GO:0050885) | 2.98154215 |
| 75 | cell migration in hindbrain (GO:0021535) | 2.97933346 |
| 76 | C4-dicarboxylate transport (GO:0015740) | 2.97389621 |
| 77 | regulation of cell communication by electrical coupling (GO:0010649) | 2.96142210 |
| 78 | response to histamine (GO:0034776) | 2.95598736 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 2.95412298 |
| 80 | synapse assembly (GO:0007416) | 2.95284554 |
| 81 | innervation (GO:0060384) | 2.94189121 |
| 82 | behavioral defense response (GO:0002209) | 2.92564817 |
| 83 | behavioral fear response (GO:0001662) | 2.92564817 |
| 84 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.91161344 |
| 85 | positive regulation of neurotransmitter transport (GO:0051590) | 2.90892540 |
| 86 | organelle transport along microtubule (GO:0072384) | 2.89763647 |
| 87 | auditory behavior (GO:0031223) | 2.89526998 |
| 88 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.89075544 |
| 89 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.88994694 |
| 90 | regulation of dendritic spine development (GO:0060998) | 2.88473468 |
| 91 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.88439461 |
| 92 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.87511153 |
| 93 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.86867754 |
| 94 | startle response (GO:0001964) | 2.85996232 |
| 95 | social behavior (GO:0035176) | 2.85626906 |
| 96 | intraspecies interaction between organisms (GO:0051703) | 2.85626906 |
| 97 | learning (GO:0007612) | 2.85488428 |
| 98 | synaptic transmission (GO:0007268) | 2.85159831 |
| 99 | prepulse inhibition (GO:0060134) | 2.84305336 |
| 100 | membrane hyperpolarization (GO:0060081) | 2.83909112 |
| 101 | positive regulation of synapse assembly (GO:0051965) | 2.83219622 |
| 102 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.82164553 |
| 103 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.82151036 |
| 104 | DNA double-strand break processing (GO:0000729) | 2.82090152 |
| 105 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.81885889 |
| 106 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.81724446 |
| 107 | response to auditory stimulus (GO:0010996) | 2.79884505 |
| 108 | positive regulation of mitochondrial fission (GO:0090141) | 2.79488728 |
| 109 | behavioral response to nicotine (GO:0035095) | 2.72591807 |
| 110 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.72459878 |
| 111 | mechanosensory behavior (GO:0007638) | 2.72451227 |
| 112 | neural tube formation (GO:0001841) | 2.67617198 |
| 113 | protein neddylation (GO:0045116) | 2.63220684 |
| 114 | regulation of sarcomere organization (GO:0060297) | 2.59219857 |
| 115 | nonmotile primary cilium assembly (GO:0035058) | 2.58387154 |
| 116 | neuromuscular synaptic transmission (GO:0007274) | 2.58275865 |
| 117 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.57857316 |
| 118 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.54968697 |
| 119 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.53813225 |
| 120 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.51644919 |
| 121 | ribonucleoprotein complex disassembly (GO:0032988) | 2.48553521 |
| 122 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.46277049 |
| 123 | regulation of membrane repolarization (GO:0060306) | 2.43814022 |
| 124 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.40765443 |
| 125 | negative regulation of heart rate (GO:0010459) | 2.40750890 |
| 126 | regulation of relaxation of muscle (GO:1901077) | 2.39638453 |
| 127 | glycosphingolipid biosynthetic process (GO:0006688) | 2.39324175 |
| 128 | negative regulation of neurotransmitter transport (GO:0051589) | 2.37188131 |
| 129 | negative regulation of DNA recombination (GO:0045910) | 2.37176848 |
| 130 | response to pheromone (GO:0019236) | 2.35514100 |
| 131 | regulation of cilium movement (GO:0003352) | 2.35213544 |
| 132 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.34637401 |
| 133 | neurotransmitter uptake (GO:0001504) | 2.32307488 |
| 134 | synapse organization (GO:0050808) | 2.30009039 |
| 135 | cullin deneddylation (GO:0010388) | 2.25581160 |
| 136 | limb bud formation (GO:0060174) | 2.24701113 |
| 137 | regulation of coenzyme metabolic process (GO:0051196) | 2.24135748 |
| 138 | regulation of cofactor metabolic process (GO:0051193) | 2.24135748 |
| 139 | negative regulation of response to food (GO:0032096) | 2.23929877 |
| 140 | negative regulation of appetite (GO:0032099) | 2.23929877 |
| 141 | muscle filament sliding (GO:0030049) | 2.23889133 |
| 142 | actin-myosin filament sliding (GO:0033275) | 2.23889133 |
| 143 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.22776102 |
| 144 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.22583144 |
| 145 | microtubule anchoring (GO:0034453) | 2.21379327 |
| 146 | mitochondrion transport along microtubule (GO:0047497) | 2.20859923 |
| 147 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.20859923 |
| 148 | adult walking behavior (GO:0007628) | 2.19487584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.09178724 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.69494885 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09380554 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02932123 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.97921367 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.66014489 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.66014489 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.59256582 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57178581 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54431608 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53304102 |
| 12 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.49765024 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48129754 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.45486667 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.41809745 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.39995435 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.33374650 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.21552206 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.19287457 |
| 20 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13454376 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.11618689 |
| 22 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11307364 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.09584621 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.07676803 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.01675630 |
| 26 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.99105125 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.92674258 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.92662434 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 1.90349049 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.89448439 |
| 31 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.88840536 |
| 32 | * AR_21572438_ChIP-Seq_LNCaP_Human | 1.88158248 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86244481 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.80996488 |
| 35 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.80837796 |
| 36 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76073834 |
| 37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62202043 |
| 38 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61699173 |
| 39 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57738860 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56240906 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.54745306 |
| 42 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.54744593 |
| 43 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.52166631 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.50173214 |
| 45 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.46945879 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.46479909 |
| 47 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46070221 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.45931074 |
| 49 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.41964422 |
| 50 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41815206 |
| 51 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.41353882 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40954856 |
| 53 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40704172 |
| 54 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.40414444 |
| 55 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.39861393 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38671051 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37077221 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36259004 |
| 59 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.35938077 |
| 60 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33823895 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33304316 |
| 62 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32782453 |
| 63 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.32272200 |
| 64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32150411 |
| 65 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.31343966 |
| 66 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.31063937 |
| 67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.31063937 |
| 68 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.30975854 |
| 69 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.30877627 |
| 70 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30660700 |
| 71 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.30552496 |
| 72 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28690939 |
| 73 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28481933 |
| 74 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27463610 |
| 75 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.27129774 |
| 76 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24910610 |
| 77 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24461084 |
| 78 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.22142408 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22050939 |
| 80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.21881511 |
| 81 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.21580725 |
| 82 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.21500566 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21310889 |
| 84 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.21119408 |
| 85 | AR_19668381_ChIP-Seq_PC3_Human | 1.19911743 |
| 86 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17720658 |
| 87 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.16706870 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16482933 |
| 89 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.15403140 |
| 90 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14975518 |
| 91 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.14927175 |
| 92 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.14405751 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14196848 |
| 94 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.14144068 |
| 95 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13958505 |
| 96 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.13346096 |
| 97 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.13144674 |
| 98 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.12296970 |
| 99 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12003290 |
| 100 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11824797 |
| 101 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11646602 |
| 102 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.10444035 |
| 103 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10255476 |
| 104 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08207388 |
| 105 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07512799 |
| 106 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07184719 |
| 107 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07167774 |
| 108 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.06800178 |
| 109 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.06800178 |
| 110 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.05768394 |
| 111 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.05706480 |
| 112 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05620761 |
| 113 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05478830 |
| 114 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04447181 |
| 115 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04390005 |
| 116 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04380994 |
| 117 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04380994 |
| 118 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03964350 |
| 119 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02978337 |
| 120 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02810667 |
| 121 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.02211869 |
| 122 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01939413 |
| 123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01047881 |
| 124 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00952904 |
| 125 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.00763789 |
| 126 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00071890 |
| 127 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99884473 |
| 128 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99222305 |
| 129 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99013284 |
| 130 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98239733 |
| 131 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97286521 |
| 132 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96267295 |
| 133 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95775453 |
| 134 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95213849 |
| 135 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94688503 |
| 136 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94646193 |
| 137 | JUN_21703547_ChIP-Seq_K562_Human | 0.93550444 |
| 138 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92871413 |
| 139 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92201080 |
| 140 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91532439 |
| 141 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91469903 |
| 142 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90526546 |
| 143 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.89897885 |
| 144 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88914783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.81369801 |
| 2 | MP0003880_abnormal_central_pattern | 4.74700263 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.89706306 |
| 4 | MP0004270_analgesia | 3.66069951 |
| 5 | MP0009745_abnormal_behavioral_response | 3.14803328 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.14285422 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.91612432 |
| 8 | MP0002064_seizures | 2.89665117 |
| 9 | MP0009046_muscle_twitch | 2.83332735 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.65178201 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.58282654 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.55510498 |
| 13 | MP0008877_abnormal_DNA_methylation | 2.50361420 |
| 14 | MP0002272_abnormal_nervous_system | 2.41056327 |
| 15 | MP0001486_abnormal_startle_reflex | 2.34864379 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.29832825 |
| 17 | MP0002736_abnormal_nociception_after | 2.29725039 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.09844902 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.09013016 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.06296464 |
| 21 | MP0002822_catalepsy | 2.05921003 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.01494633 |
| 23 | MP0006276_abnormal_autonomic_nervous | 1.95930389 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.95433481 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.95417658 |
| 26 | MP0001970_abnormal_pain_threshold | 1.90339849 |
| 27 | MP0000778_abnormal_nervous_system | 1.89486432 |
| 28 | MP0002184_abnormal_innervation | 1.89324905 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.83023027 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.75942975 |
| 31 | MP0004147_increased_porphyrin_level | 1.75033641 |
| 32 | MP0000751_myopathy | 1.72761210 |
| 33 | MP0001984_abnormal_olfaction | 1.72688892 |
| 34 | MP0004924_abnormal_behavior | 1.72147264 |
| 35 | MP0005386_behavior/neurological_phenoty | 1.72147264 |
| 36 | MP0002102_abnormal_ear_morphology | 1.71844016 |
| 37 | MP0006292_abnormal_olfactory_placode | 1.68193420 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.67231574 |
| 39 | MP0008569_lethality_at_weaning | 1.66208816 |
| 40 | MP0004858_abnormal_nervous_system | 1.59024853 |
| 41 | MP0003122_maternal_imprinting | 1.58977601 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.58802783 |
| 43 | MP0003787_abnormal_imprinting | 1.56767716 |
| 44 | MP0008789_abnormal_olfactory_epithelium | 1.54753116 |
| 45 | MP0003329_amyloid_beta_deposits | 1.53941257 |
| 46 | MP0000955_abnormal_spinal_cord | 1.50037216 |
| 47 | MP0003879_abnormal_hair_cell | 1.45563615 |
| 48 | MP0001529_abnormal_vocalization | 1.43386511 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.41746016 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.36634697 |
| 51 | MP0002066_abnormal_motor_capabilities/c | 1.35986616 |
| 52 | MP0003890_abnormal_embryonic-extraembry | 1.35884432 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.33582649 |
| 54 | MP0004215_abnormal_myocardial_fiber | 1.30650636 |
| 55 | MP0006072_abnormal_retinal_apoptosis | 1.30035295 |
| 56 | MP0003646_muscle_fatigue | 1.28871737 |
| 57 | MP0004885_abnormal_endolymph | 1.25680381 |
| 58 | MP0000749_muscle_degeneration | 1.23263128 |
| 59 | MP0001485_abnormal_pinna_reflex | 1.18989695 |
| 60 | MP0001188_hyperpigmentation | 1.15178973 |
| 61 | MP0005253_abnormal_eye_physiology | 1.15106420 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.14358449 |
| 63 | MP0001502_abnormal_circadian_rhythm | 1.13620710 |
| 64 | MP0004142_abnormal_muscle_tone | 1.12105562 |
| 65 | MP0001905_abnormal_dopamine_level | 1.11531793 |
| 66 | MP0002234_abnormal_pharynx_morphology | 1.10688038 |
| 67 | MP0003633_abnormal_nervous_system | 1.10119187 |
| 68 | MP0002152_abnormal_brain_morphology | 1.07735910 |
| 69 | MP0004085_abnormal_heartbeat | 1.05586667 |
| 70 | MP0010386_abnormal_urinary_bladder | 1.04683690 |
| 71 | MP0004484_altered_response_of | 1.04099833 |
| 72 | MP0004233_abnormal_muscle_weight | 1.00377213 |
| 73 | MP0008058_abnormal_DNA_repair | 0.99635674 |
| 74 | MP0004133_heterotaxia | 0.99611172 |
| 75 | MP0003137_abnormal_impulse_conducting | 0.98762508 |
| 76 | MP0004036_abnormal_muscle_relaxation | 0.96361753 |
| 77 | MP0001293_anophthalmia | 0.94905872 |
| 78 | MP0003631_nervous_system_phenotype | 0.94083188 |
| 79 | MP0003718_maternal_effect | 0.90779442 |
| 80 | MP0000569_abnormal_digit_pigmentation | 0.90489949 |
| 81 | MP0003567_abnormal_fetal_cardiomyocyte | 0.88490027 |
| 82 | MP0006035_abnormal_mitochondrial_morpho | 0.87822091 |
| 83 | MP0002106_abnormal_muscle_physiology | 0.87140317 |
| 84 | MP0003136_yellow_coat_color | 0.86348270 |
| 85 | MP0002069_abnormal_eating/drinking_beha | 0.85616223 |
| 86 | MP0003119_abnormal_digestive_system | 0.85581996 |
| 87 | MP0002751_abnormal_autonomic_nervous | 0.83955917 |
| 88 | MP0002229_neurodegeneration | 0.83733412 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 0.82921738 |
| 90 | MP0001299_abnormal_eye_distance/ | 0.82536866 |
| 91 | MP0004084_abnormal_cardiac_muscle | 0.81192028 |
| 92 | MP0005499_abnormal_olfactory_system | 0.80338202 |
| 93 | MP0005394_taste/olfaction_phenotype | 0.80338202 |
| 94 | MP0005248_abnormal_Harderian_gland | 0.80104509 |
| 95 | MP0005535_abnormal_body_temperature | 0.79973434 |
| 96 | MP0004742_abnormal_vestibular_system | 0.78598437 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.78268616 |
| 98 | MP0001963_abnormal_hearing_physiology | 0.78142534 |
| 99 | MP0002752_abnormal_somatic_nervous | 0.76327764 |
| 100 | MP0005620_abnormal_muscle_contractility | 0.75843612 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.75345033 |
| 102 | MP0004130_abnormal_muscle_cell | 0.75099290 |
| 103 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74199808 |
| 104 | MP0002233_abnormal_nose_morphology | 0.73719690 |
| 105 | MP0005551_abnormal_eye_electrophysiolog | 0.72965812 |
| 106 | MP0002938_white_spotting | 0.72850537 |
| 107 | MP0003283_abnormal_digestive_organ | 0.72247948 |
| 108 | MP0004043_abnormal_pH_regulation | 0.72121401 |
| 109 | MP0003385_abnormal_body_wall | 0.71781317 |
| 110 | MP0003937_abnormal_limbs/digits/tail_de | 0.71515663 |
| 111 | MP0003634_abnormal_glial_cell | 0.71455781 |
| 112 | MP0003698_abnormal_male_reproductive | 0.71399982 |
| 113 | MP0002638_abnormal_pupillary_reflex | 0.71053465 |
| 114 | MP0008872_abnormal_physiological_respon | 0.70600601 |
| 115 | MP0005187_abnormal_penis_morphology | 0.69424484 |
| 116 | MP0005623_abnormal_meninges_morphology | 0.69146125 |
| 117 | MP0001177_atelectasis | 0.68628940 |
| 118 | MP0008874_decreased_physiological_sensi | 0.67811415 |
| 119 | MP0003123_paternal_imprinting | 0.66513244 |
| 120 | MP0003121_genomic_imprinting | 0.66096655 |
| 121 | MP0002972_abnormal_cardiac_muscle | 0.64361501 |
| 122 | MP0000747_muscle_weakness | 0.63232555 |
| 123 | MP0003632_abnormal_nervous_system | 0.62485942 |
| 124 | MP0001943_abnormal_respiration | 0.60585984 |
| 125 | MP0003861_abnormal_nervous_system | 0.58971475 |
| 126 | MP0001664_abnormal_digestion | 0.58894877 |
| 127 | MP0004510_myositis | 0.57334413 |
| 128 | MP0002090_abnormal_vision | 0.56812238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.33249344 |
| 2 | Myokymia (HP:0002411) | 5.80953426 |
| 3 | Focal seizures (HP:0007359) | 5.24934993 |
| 4 | Visual hallucinations (HP:0002367) | 5.04548313 |
| 5 | Atonic seizures (HP:0010819) | 4.67301358 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.56901008 |
| 7 | Febrile seizures (HP:0002373) | 4.21483015 |
| 8 | Absence seizures (HP:0002121) | 4.09371324 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.01856943 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 3.68765794 |
| 11 | Dialeptic seizures (HP:0011146) | 3.65868872 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 3.55633249 |
| 13 | Broad-based gait (HP:0002136) | 3.42025072 |
| 14 | Action tremor (HP:0002345) | 3.35427874 |
| 15 | Hyperventilation (HP:0002883) | 3.33930430 |
| 16 | Poor eye contact (HP:0000817) | 3.19040547 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 3.02149935 |
| 18 | Progressive inability to walk (HP:0002505) | 2.96951647 |
| 19 | Pheochromocytoma (HP:0002666) | 2.95026997 |
| 20 | Ankle clonus (HP:0011448) | 2.94118638 |
| 21 | Amblyopia (HP:0000646) | 2.92074560 |
| 22 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.90831540 |
| 23 | Impaired social interactions (HP:0000735) | 2.87798583 |
| 24 | Abnormal social behavior (HP:0012433) | 2.87798583 |
| 25 | Dysdiadochokinesis (HP:0002075) | 2.86824500 |
| 26 | Depression (HP:0000716) | 2.86677962 |
| 27 | Anxiety (HP:0000739) | 2.80913785 |
| 28 | Rimmed vacuoles (HP:0003805) | 2.80713477 |
| 29 | Gaze-evoked nystagmus (HP:0000640) | 2.79689419 |
| 30 | Medial flaring of the eyebrow (HP:0010747) | 2.78793636 |
| 31 | Truncal ataxia (HP:0002078) | 2.74547881 |
| 32 | Abnormal eating behavior (HP:0100738) | 2.72215086 |
| 33 | Insidious onset (HP:0003587) | 2.71988181 |
| 34 | Termporal pattern (HP:0011008) | 2.71988181 |
| 35 | Excessive salivation (HP:0003781) | 2.70149097 |
| 36 | Drooling (HP:0002307) | 2.70149097 |
| 37 | Neuroendocrine neoplasm (HP:0100634) | 2.69748263 |
| 38 | Papilledema (HP:0001085) | 2.66957549 |
| 39 | Mutism (HP:0002300) | 2.65873625 |
| 40 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.65624051 |
| 41 | Abnormality of the labia minora (HP:0012880) | 2.63747443 |
| 42 | Calf muscle hypertrophy (HP:0008981) | 2.63613318 |
| 43 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.62978544 |
| 44 | Muscle fiber inclusion bodies (HP:0100299) | 2.58453236 |
| 45 | Bundle branch block (HP:0011710) | 2.58188808 |
| 46 | Congenital primary aphakia (HP:0007707) | 2.57022358 |
| 47 | Nemaline bodies (HP:0003798) | 2.54937954 |
| 48 | Genetic anticipation (HP:0003743) | 2.54561259 |
| 49 | Limb dystonia (HP:0002451) | 2.54003745 |
| 50 | Genital tract atresia (HP:0001827) | 2.46975848 |
| 51 | Epileptiform EEG discharges (HP:0011182) | 2.45927088 |
| 52 | Urinary urgency (HP:0000012) | 2.43511345 |
| 53 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.43489991 |
| 54 | Dysmetria (HP:0001310) | 2.42946069 |
| 55 | Fetal akinesia sequence (HP:0001989) | 2.41283220 |
| 56 | Vaginal atresia (HP:0000148) | 2.40637906 |
| 57 | Colon cancer (HP:0003003) | 2.37580937 |
| 58 | EEG with generalized epileptiform discharges (HP:0011198) | 2.35655732 |
| 59 | Inability to walk (HP:0002540) | 2.33658209 |
| 60 | Postural instability (HP:0002172) | 2.33302493 |
| 61 | Agitation (HP:0000713) | 2.33246421 |
| 62 | Absent speech (HP:0001344) | 2.30159075 |
| 63 | Polyphagia (HP:0002591) | 2.29064704 |
| 64 | Nephrogenic diabetes insipidus (HP:0009806) | 2.28651792 |
| 65 | Ventricular fibrillation (HP:0001663) | 2.26619441 |
| 66 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.24295663 |
| 67 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.24295663 |
| 68 | Hypsarrhythmia (HP:0002521) | 2.23070550 |
| 69 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.22646350 |
| 70 | Hyperglycinemia (HP:0002154) | 2.17779410 |
| 71 | Impaired smooth pursuit (HP:0007772) | 2.16727217 |
| 72 | Nephronophthisis (HP:0000090) | 2.14861826 |
| 73 | Type II lissencephaly (HP:0007260) | 2.13306652 |
| 74 | Lissencephaly (HP:0001339) | 2.13084314 |
| 75 | Hemiparesis (HP:0001269) | 2.11934213 |
| 76 | Torticollis (HP:0000473) | 2.11703036 |
| 77 | Dysmetric saccades (HP:0000641) | 2.11165112 |
| 78 | Scanning speech (HP:0002168) | 2.10877787 |
| 79 | Sudden death (HP:0001699) | 2.09096210 |
| 80 | Bradykinesia (HP:0002067) | 2.07502901 |
| 81 | Abnormality of the corticospinal tract (HP:0002492) | 2.06534478 |
| 82 | Cerebral inclusion bodies (HP:0100314) | 2.05396779 |
| 83 | Spastic gait (HP:0002064) | 2.04350607 |
| 84 | Megalencephaly (HP:0001355) | 2.03055625 |
| 85 | Oligodactyly (hands) (HP:0001180) | 2.01057479 |
| 86 | Gait imbalance (HP:0002141) | 2.01051340 |
| 87 | Papillary thyroid carcinoma (HP:0002895) | 1.99518061 |
| 88 | Abnormality of binocular vision (HP:0011514) | 1.99333186 |
| 89 | Diplopia (HP:0000651) | 1.99333186 |
| 90 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.98664844 |
| 91 | Hypoplasia of the brainstem (HP:0002365) | 1.98664844 |
| 92 | Focal dystonia (HP:0004373) | 1.98589374 |
| 93 | Optic nerve hypoplasia (HP:0000609) | 1.98128828 |
| 94 | Abnormality of the lower motor neuron (HP:0002366) | 1.97254503 |
| 95 | Pachygyria (HP:0001302) | 1.96978670 |
| 96 | Lower limb muscle weakness (HP:0007340) | 1.95930200 |
| 97 | Cortical dysplasia (HP:0002539) | 1.94996720 |
| 98 | Amyotrophic lateral sclerosis (HP:0007354) | 1.94797688 |
| 99 | Stereotypic behavior (HP:0000733) | 1.94387653 |
| 100 | Exercise-induced myalgia (HP:0003738) | 1.94005287 |
| 101 | Renal cortical cysts (HP:0000803) | 1.93895285 |
| 102 | Volvulus (HP:0002580) | 1.91744935 |
| 103 | Hypoventilation (HP:0002791) | 1.89823752 |
| 104 | Neurofibrillary tangles (HP:0002185) | 1.89770346 |
| 105 | Pancreatic fibrosis (HP:0100732) | 1.88979427 |
| 106 | Hyperglycinuria (HP:0003108) | 1.88303746 |
| 107 | Myotonia (HP:0002486) | 1.87489452 |
| 108 | Hyperthyroidism (HP:0000836) | 1.86539570 |
| 109 | Intention tremor (HP:0002080) | 1.86455587 |
| 110 | Chronic hepatic failure (HP:0100626) | 1.85963339 |
| 111 | Prolonged QT interval (HP:0001657) | 1.85710897 |
| 112 | Poor coordination (HP:0002370) | 1.85641692 |
| 113 | Failure to thrive in infancy (HP:0001531) | 1.85582965 |
| 114 | Generalized myoclonic seizures (HP:0002123) | 1.85281321 |
| 115 | Abnormal EKG (HP:0003115) | 1.85207421 |
| 116 | Intestinal atresia (HP:0011100) | 1.84993664 |
| 117 | Pancreatic cysts (HP:0001737) | 1.84934943 |
| 118 | Impaired vibratory sensation (HP:0002495) | 1.84518790 |
| 119 | Syncope (HP:0001279) | 1.83838438 |
| 120 | Inappropriate behavior (HP:0000719) | 1.82749938 |
| 121 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82226774 |
| 122 | Blue irides (HP:0000635) | 1.81792918 |
| 123 | Protruding tongue (HP:0010808) | 1.81565207 |
| 124 | Abnormality of the renal medulla (HP:0100957) | 1.80553875 |
| 125 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.79901214 |
| 126 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.79215560 |
| 127 | Cerebral hypomyelination (HP:0006808) | 1.79206422 |
| 128 | Obstructive sleep apnea (HP:0002870) | 1.79158451 |
| 129 | True hermaphroditism (HP:0010459) | 1.78656717 |
| 130 | Specific learning disability (HP:0001328) | 1.78254553 |
| 131 | Retinal dysplasia (HP:0007973) | 1.78050616 |
| 132 | Lower limb amyotrophy (HP:0007210) | 1.77402842 |
| 133 | Shoulder girdle muscle weakness (HP:0003547) | 1.77268121 |
| 134 | Left ventricular hypertrophy (HP:0001712) | 1.77126330 |
| 135 | Abnormality of salivation (HP:0100755) | 1.75234889 |
| 136 | Abnormality of midbrain morphology (HP:0002418) | 1.74494364 |
| 137 | Molar tooth sign on MRI (HP:0002419) | 1.74494364 |
| 138 | Craniofacial dystonia (HP:0012179) | 1.73957220 |
| 139 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.73640970 |
| 140 | Abnormality of alanine metabolism (HP:0010916) | 1.72874585 |
| 141 | Hyperalaninemia (HP:0003348) | 1.72874585 |
| 142 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.72874585 |
| 143 | Abnormality of the renal cortex (HP:0011035) | 1.72771447 |
| 144 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.72751966 |
| 145 | Abnormality of the calf musculature (HP:0001430) | 1.72106782 |
| 146 | Abnormality of glycine metabolism (HP:0010895) | 1.70235595 |
| 147 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.70235595 |
| 148 | Dyskinesia (HP:0100660) | 1.69641881 |
| 149 | Acute encephalopathy (HP:0006846) | 1.67346690 |
| 150 | Hepatoblastoma (HP:0002884) | 1.67219881 |
| 151 | Broad foot (HP:0001769) | 1.67117475 |
| 152 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.66342262 |
| 153 | Methylmalonic acidemia (HP:0002912) | 1.66298545 |
| 154 | Poor suck (HP:0002033) | 1.66267253 |
| 155 | Spastic tetraplegia (HP:0002510) | 1.66024007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.17132801 |
| 2 | MAP3K9 | 3.78363640 |
| 3 | MARK1 | 3.74863897 |
| 4 | MAP3K4 | 3.35823106 |
| 5 | EPHA4 | 3.33927111 |
| 6 | MAP2K7 | 2.76822476 |
| 7 | OBSCN | 2.69900306 |
| 8 | CASK | 2.65961140 |
| 9 | MINK1 | 2.63580188 |
| 10 | MAP3K12 | 2.56063679 |
| 11 | TRIM28 | 2.45828767 |
| 12 | DAPK2 | 2.34551053 |
| 13 | MAP2K4 | 2.19441282 |
| 14 | MAP4K2 | 1.95413079 |
| 15 | PAK6 | 1.94454307 |
| 16 | NTRK2 | 1.90710200 |
| 17 | KSR2 | 1.88371547 |
| 18 | PHKG1 | 1.76124782 |
| 19 | PHKG2 | 1.76124782 |
| 20 | PLK2 | 1.67714659 |
| 21 | KSR1 | 1.63070897 |
| 22 | MAPK13 | 1.59776096 |
| 23 | PRKD3 | 1.56903971 |
| 24 | NTRK1 | 1.54352519 |
| 25 | STK38L | 1.52324724 |
| 26 | CAMKK1 | 1.48540670 |
| 27 | DYRK2 | 1.47833814 |
| 28 | PNCK | 1.46128967 |
| 29 | DAPK1 | 1.45948379 |
| 30 | CDK5 | 1.40732074 |
| 31 | RIPK4 | 1.34993108 |
| 32 | GRK5 | 1.32651385 |
| 33 | BMPR1B | 1.30826263 |
| 34 | LATS2 | 1.30746147 |
| 35 | CDK19 | 1.22196837 |
| 36 | CSNK1G3 | 1.22184598 |
| 37 | MKNK2 | 1.17759587 |
| 38 | ARAF | 1.16571572 |
| 39 | STK39 | 1.16356365 |
| 40 | MAP3K2 | 1.14981471 |
| 41 | PRKCG | 1.12950003 |
| 42 | SIK2 | 1.12814086 |
| 43 | PRPF4B | 1.12616556 |
| 44 | CSNK1G1 | 1.12563450 |
| 45 | CSNK1A1L | 1.11995734 |
| 46 | NUAK1 | 1.09092588 |
| 47 | TNIK | 1.07628528 |
| 48 | STK38 | 1.07101248 |
| 49 | UHMK1 | 1.06919319 |
| 50 | MKNK1 | 1.06356314 |
| 51 | CAMK2A | 1.05179501 |
| 52 | ACVR1B | 1.03317009 |
| 53 | DYRK3 | 1.02412727 |
| 54 | ZAK | 1.00363383 |
| 55 | CAMKK2 | 0.96791412 |
| 56 | PLK3 | 0.96262994 |
| 57 | LMTK2 | 0.96192234 |
| 58 | PAK3 | 0.91394769 |
| 59 | NME1 | 0.90508191 |
| 60 | EPHA3 | 0.89690826 |
| 61 | RET | 0.89584742 |
| 62 | SGK223 | 0.87437424 |
| 63 | SGK494 | 0.87437424 |
| 64 | PLK4 | 0.86308592 |
| 65 | SRPK1 | 0.85880742 |
| 66 | TYRO3 | 0.84322400 |
| 67 | FES | 0.81849942 |
| 68 | STK11 | 0.81684093 |
| 69 | WNK3 | 0.81203942 |
| 70 | CDK14 | 0.81193172 |
| 71 | SGK2 | 0.80439882 |
| 72 | CDK18 | 0.79460082 |
| 73 | VRK1 | 0.76407645 |
| 74 | CAMK2B | 0.75872328 |
| 75 | CDK15 | 0.75571702 |
| 76 | BCKDK | 0.75304915 |
| 77 | CSNK1G2 | 0.74547915 |
| 78 | EIF2AK3 | 0.73217361 |
| 79 | CAMK1 | 0.73115578 |
| 80 | WNK4 | 0.72593820 |
| 81 | CCNB1 | 0.72208121 |
| 82 | TAOK1 | 0.71612752 |
| 83 | SGK1 | 0.67901061 |
| 84 | DYRK1A | 0.67280703 |
| 85 | ERBB3 | 0.66987085 |
| 86 | PKN1 | 0.66758549 |
| 87 | PINK1 | 0.66456652 |
| 88 | PRKCH | 0.65847346 |
| 89 | CDK11A | 0.64637654 |
| 90 | PTK2B | 0.64434465 |
| 91 | MAP3K13 | 0.63858010 |
| 92 | MUSK | 0.63856405 |
| 93 | PRKCE | 0.63057936 |
| 94 | OXSR1 | 0.62569588 |
| 95 | FER | 0.60985379 |
| 96 | NEK1 | 0.60165641 |
| 97 | LIMK1 | 0.60026572 |
| 98 | MST4 | 0.59516436 |
| 99 | RAF1 | 0.59209895 |
| 100 | AKT3 | 0.57844432 |
| 101 | PDK4 | 0.57605454 |
| 102 | PDK3 | 0.57605454 |
| 103 | CDK3 | 0.57337208 |
| 104 | MAP3K1 | 0.57335862 |
| 105 | INSRR | 0.56691894 |
| 106 | BMPR2 | 0.56236096 |
| 107 | SGK3 | 0.56164847 |
| 108 | CAMK2D | 0.54150825 |
| 109 | CDC7 | 0.54026007 |
| 110 | GRK1 | 0.53996049 |
| 111 | NEK2 | 0.53158237 |
| 112 | MARK2 | 0.52817895 |
| 113 | CAMK1G | 0.50887358 |
| 114 | GRK7 | 0.50405273 |
| 115 | PIK3CG | 0.50126271 |
| 116 | RPS6KA4 | 0.48807661 |
| 117 | RIPK1 | 0.48525797 |
| 118 | MAP3K6 | 0.48348788 |
| 119 | CAMK4 | 0.47903817 |
| 120 | PRKCZ | 0.47448958 |
| 121 | MAP2K1 | 0.46211445 |
| 122 | BRD4 | 0.46080500 |
| 123 | CSNK1D | 0.45162914 |
| 124 | PRKG1 | 0.43903009 |
| 125 | RPS6KA3 | 0.43480334 |
| 126 | PDK1 | 0.43391671 |
| 127 | FRK | 0.43384857 |
| 128 | WNK1 | 0.42389027 |
| 129 | SCYL2 | 0.42345976 |
| 130 | BCR | 0.42123737 |
| 131 | DMPK | 0.42071231 |
| 132 | YES1 | 0.41908369 |
| 133 | PDPK1 | 0.41539269 |
| 134 | PRKACA | 0.41327113 |
| 135 | CAMK2G | 0.41115571 |
| 136 | PLK1 | 0.40648595 |
| 137 | ADRBK2 | 0.40483263 |
| 138 | ALK | 0.40057837 |
| 139 | CSNK1E | 0.40031405 |
| 140 | MAPK10 | 0.39953018 |
| 141 | CDC42BPA | 0.39625747 |
| 142 | FGFR2 | 0.39495360 |
| 143 | PRKACB | 0.39239056 |
| 144 | MAPK12 | 0.39163918 |
| 145 | RPS6KA2 | 0.37983572 |
| 146 | CSNK1A1 | 0.36864901 |
| 147 | PIK3CA | 0.36563012 |
| 148 | TSSK6 | 0.36042321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.51533212 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.12829094 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.72045961 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.60077127 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.55688978 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.53747823 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.53695738 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.36690219 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.33975229 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.32088032 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16123587 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.11321837 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.03736080 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99229343 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.95180083 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87099479 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.82755073 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.81896267 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.78430820 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.77069191 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74509786 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.70876820 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.68868306 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.64296357 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64031423 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.62957602 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.61222687 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.56466984 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.56216377 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.54365877 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51348571 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.45788169 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45777620 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.43251372 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.38323915 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.35852419 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.27817310 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.27546570 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23871182 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22067378 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.18106156 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.16630745 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.14131894 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12145320 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 1.10854873 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10306881 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.07337409 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05680296 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05195161 |
| 50 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.05018222 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 1.03173969 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02873302 |
| 53 | Basal transcription factors_Homo sapiens_hsa03022 | 0.98124182 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98003966 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94966359 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94435511 |
| 57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.92966679 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91937322 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91872650 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.91052879 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88743266 |
| 62 | RNA degradation_Homo sapiens_hsa03018 | 0.88711652 |
| 63 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.88422842 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85935443 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.85895101 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85716014 |
| 67 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.85576755 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84927019 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84816052 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84709419 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83350580 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82513724 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.79842819 |
| 74 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.79255968 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78448963 |
| 76 | Phototransduction_Homo sapiens_hsa04744 | 0.78195728 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77006005 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76980269 |
| 79 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.76084745 |
| 80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75882390 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73665011 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73462716 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72471200 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72021949 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71536619 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71471642 |
| 87 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70034496 |
| 88 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69888227 |
| 89 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.68487203 |
| 90 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67542145 |
| 91 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.66467767 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65106393 |
| 93 | Tight junction_Homo sapiens_hsa04530 | 0.63700189 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62847697 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62136413 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61439425 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60462408 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60242805 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59965537 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59625044 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.59419062 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59014884 |
| 103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57312947 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57231954 |
| 105 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.57109394 |
| 106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56686695 |
| 107 | RNA transport_Homo sapiens_hsa03013 | 0.55755246 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55215453 |
| 109 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.54545034 |
| 110 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.54385553 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54159594 |
| 112 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.53599057 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53158136 |
| 114 | Mismatch repair_Homo sapiens_hsa03430 | 0.52190049 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51728612 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51078177 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50736428 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49198655 |
| 119 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.48239252 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46787423 |
| 121 | Carbon metabolism_Homo sapiens_hsa01200 | 0.46184496 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45879862 |
| 123 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.44780021 |
| 124 | Purine metabolism_Homo sapiens_hsa00230 | 0.44731561 |
| 125 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44423669 |
| 126 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44310321 |
| 127 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44258819 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44145251 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43768093 |
| 130 | Alcoholism_Homo sapiens_hsa05034 | 0.42173370 |
| 131 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42057259 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41277425 |
| 133 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40684410 |
| 134 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40470461 |
| 135 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40316107 |
| 136 | RNA polymerase_Homo sapiens_hsa03020 | 0.40232159 |
| 137 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.38187182 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38071340 |
| 139 | Endocytosis_Homo sapiens_hsa04144 | 0.36834614 |
| 140 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35885709 |
| 141 | Melanoma_Homo sapiens_hsa05218 | 0.35243987 |
| 142 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.31217075 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.31216996 |

